tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Promising Potential of Tourmaline Bio’s TOUR006: A Strong Buy Recommendation
PremiumRatingsPromising Potential of Tourmaline Bio’s TOUR006: A Strong Buy Recommendation
2M ago
Buy Rating for Tourmaline Bio Driven by Promising Clinical Results and Market Potential
Premium
Ratings
Buy Rating for Tourmaline Bio Driven by Promising Clinical Results and Market Potential
2M ago
Tourmaline Bio Announces Positive Phase 2 Trial Results
Premium
Company Announcements
Tourmaline Bio Announces Positive Phase 2 Trial Results
2M ago
Tourmaline Bio Reports Q1 2025 Financial Results
PremiumCompany AnnouncementsTourmaline Bio Reports Q1 2025 Financial Results
3M ago
Tourmaline Bio’s Promising Clinical Trials and Strong Financial Position Justify Buy Rating
Premium
Ratings
Tourmaline Bio’s Promising Clinical Trials and Strong Financial Position Justify Buy Rating
3M ago
Tourmaline Bio: Strong Financial Position and Promising Phase II Study Results Drive Buy Rating
Premium
Ratings
Tourmaline Bio: Strong Financial Position and Promising Phase II Study Results Drive Buy Rating
3M ago
Tourmaline Bio price target lowered to $63 from $74 at Truist
PremiumThe FlyTourmaline Bio price target lowered to $63 from $74 at Truist
4M ago
Truist biotech analyst holds an analyst/industry conference call
Premium
The Fly
Truist biotech analyst holds an analyst/industry conference call
4M ago
Tourmaline Bio’s TOUR006: Potential Best-in-Class IL-6 Treatment with Strategic Market Positioning
Premium
Ratings
Tourmaline Bio’s TOUR006: Potential Best-in-Class IL-6 Treatment with Strategic Market Positioning
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100